EU to cease holdup of Indian generics

It's not exactly peace in the Middle East, but India and Europe appear to have settled their trade differences. India says it will withdraw its WTO complaint against the EU, while EU officials say they will stop claiming patent infringement while delaying Indian generic-drug shipments. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.